UCL 2077, >=98% (HPLC), solid

UCL 2077, >=98% (HPLC), solid

Application

UCL 2077 has been used for slow afterhyperpolarization (sAHP) studies in thalamic paraventricular nucleus (PVT) neurons. UCL 2077 has also been used for studying its effects on the increase in excitability of hippocampal pyramidal cells.

Biochem/physiol Actions

UCL 2077 is a slow afterhyperpolarization (sAHP) channel blocker.

Packaging

5, 25 mg in glass bottle

Preparation Note

UCL 2077 is soluble in DMSO at a concentration >20 mg/ml and is insoluble in water.

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level InChI key InChI Manufacturer Solubility Form Assay Price Quantity
3576990 UCL 2077, >=98% (HPLC), solid white 100 PQFNWDHABGBCHB-UHFFFAOYSA-N 1S/C25H22N2/c1-4-12-22(13-5-1)25(23-14-6-2-7-15-23,24-16-8-3-9-17-24)27-20-21-11-10-18-26-19-21/h1-19,27H,20H2
£759.11 (exc VAT) per 25MG
-
+
3576991 UCL 2077, >=98% (HPLC), solid white 100 PQFNWDHABGBCHB-UHFFFAOYSA-N 1S/C25H22N2/c1-4-12-22(13-5-1)25(23-14-6-2-7-15-23,24-16-8-3-9-17-24)27-20-21-11-10-18-26-19-21/h1-19,27H,20H2
£174.11 (exc VAT) per 5MG
-
+